🕵️ Beyondspring Inc. ($BYSI)
SEC insider & ownership activity, last 12 months · CIK 1677940 · every row links its SEC filing
Over the last 12 months insiders sold $2.0M with no open-market buying against it. Decheng Capital China Life Sciences USD Fund III, L.P. sold $2.0M (Jun–Oct). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 1 seller, $2.0M (63 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Decheng Capital China Life Sciences USD Fund III, L.P. | 0 | – | 63 | $2.0M | Oct 17, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Lan Huang | 14.1% | 13G | May 15, 2026 | filing ↗ | |
| Linqing Jia | 14.1% | 13G | May 15, 2026 | filing ↗ | |
| Xiangmin Cui | 9.2% | 13G | Feb 13, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jun 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 4, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 4, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 4, 2026 | filing ↗ |
| Earnings (2.02) | May 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 13, 2026 | filing ↗ |
| Earnings (2.02) | Mar 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 25, 2026 | filing ↗ |
| Other events (8.01) | Dec 15, 2025 | filing ↗ |
| Material agreement (1.01) | Nov 17, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 17, 2025 | filing ↗ |
| Earnings (2.02) | Nov 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 12, 2025 | filing ↗ |
| Material agreement (1.01) | Sep 22, 2025 | filing ↗ |
| Other events (8.01) | Sep 22, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 22, 2025 | filing ↗ |
| Shareholder vote (5.07) | Sep 15, 2025 | filing ↗ |
| Earnings (2.02) | Aug 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 13, 2025 | filing ↗ |